Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 10 | 2025 | 664 | 3.080 |
Why?
|
| Obesity | 15 | 2018 | 814 | 2.810 |
Why?
|
| African Americans | 11 | 2019 | 439 | 1.880 |
Why?
|
| Social Determinants of Health | 2 | 2024 | 38 | 1.640 |
Why?
|
| Weight Loss | 13 | 2022 | 294 | 1.610 |
Why?
|
| Diabetes Mellitus | 6 | 2023 | 452 | 1.370 |
Why?
|
| Humans | 54 | 2025 | 17314 | 1.320 |
Why?
|
| Self Care | 6 | 2017 | 144 | 1.310 |
Why?
|
| Weight Reduction Programs | 4 | 2018 | 49 | 1.280 |
Why?
|
| Overweight | 4 | 2019 | 266 | 1.170 |
Why?
|
| Behavior Therapy | 5 | 2018 | 126 | 1.150 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2022 | 535 | 1.100 |
Why?
|
| Patient Education as Topic | 4 | 2017 | 193 | 1.090 |
Why?
|
| Self-Management | 2 | 2025 | 24 | 0.990 |
Why?
|
| Health Behavior | 7 | 2022 | 346 | 0.920 |
Why?
|
| Life Style | 4 | 2018 | 316 | 0.910 |
Why?
|
| Female | 33 | 2025 | 12396 | 0.880 |
Why?
|
| Racism | 1 | 2024 | 21 | 0.850 |
Why?
|
| Prenatal Care | 1 | 2025 | 127 | 0.830 |
Why?
|
| Health Equity | 1 | 2023 | 22 | 0.770 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 197 | 0.770 |
Why?
|
| Primary Health Care | 3 | 2017 | 726 | 0.760 |
Why?
|
| Male | 27 | 2025 | 9804 | 0.750 |
Why?
|
| Prediabetic State | 2 | 2021 | 52 | 0.740 |
Why?
|
| Adult | 21 | 2025 | 7500 | 0.720 |
Why?
|
| Blood Glucose | 1 | 2023 | 314 | 0.700 |
Why?
|
| Referral and Consultation | 2 | 2017 | 157 | 0.620 |
Why?
|
| Decision Making | 3 | 2016 | 171 | 0.580 |
Why?
|
| Feeding Behavior | 3 | 2014 | 163 | 0.570 |
Why?
|
| Glycated Hemoglobin A | 5 | 2022 | 184 | 0.560 |
Why?
|
| Centers for Medicare and Medicaid Services (U.S.) | 1 | 2017 | 4 | 0.550 |
Why?
|
| Middle Aged | 17 | 2022 | 7836 | 0.540 |
Why?
|
| Behavioral Medicine | 1 | 2017 | 4 | 0.540 |
Why?
|
| Obesity Management | 1 | 2017 | 4 | 0.530 |
Why?
|
| Societies, Medical | 1 | 2017 | 71 | 0.520 |
Why?
|
| Metabolic Syndrome | 2 | 2018 | 65 | 0.520 |
Why?
|
| Social Isolation | 2 | 2025 | 16 | 0.520 |
Why?
|
| Surveys and Questionnaires | 8 | 2025 | 1282 | 0.510 |
Why?
|
| Physicians | 1 | 2017 | 117 | 0.510 |
Why?
|
| Psychometrics | 3 | 2014 | 119 | 0.490 |
Why?
|
| Research Design | 2 | 2021 | 336 | 0.480 |
Why?
|
| Exercise | 6 | 2025 | 515 | 0.470 |
Why?
|
| Autonomic Nervous System | 1 | 2015 | 3 | 0.470 |
Why?
|
| Heart Rate | 1 | 2015 | 38 | 0.460 |
Why?
|
| Asthma | 3 | 2011 | 400 | 0.460 |
Why?
|
| Emigrants and Immigrants | 1 | 2015 | 27 | 0.450 |
Why?
|
| Problem Solving | 1 | 2014 | 8 | 0.450 |
Why?
|
| Lost to Follow-Up | 1 | 2014 | 2 | 0.430 |
Why?
|
| Stress, Psychological | 1 | 2015 | 134 | 0.420 |
Why?
|
| Aged | 10 | 2025 | 6084 | 0.410 |
Why?
|
| Electronic Health Records | 2 | 2019 | 704 | 0.410 |
Why?
|
| Models, Statistical | 1 | 2013 | 170 | 0.390 |
Why?
|
| Psychosomatic Medicine | 1 | 2012 | 1 | 0.380 |
Why?
|
| Chronic Disease | 1 | 2014 | 397 | 0.370 |
Why?
|
| Models, Psychological | 1 | 2012 | 21 | 0.370 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 5 | 0.370 |
Why?
|
| Body Mass Index | 8 | 2019 | 937 | 0.350 |
Why?
|
| Medicare | 3 | 2025 | 192 | 0.350 |
Why?
|
| Telemedicine | 2 | 2025 | 181 | 0.320 |
Why?
|
| Gastric Bypass | 2 | 2022 | 71 | 0.270 |
Why?
|
| Young Adult | 5 | 2024 | 2465 | 0.270 |
Why?
|
| Fruit | 3 | 2023 | 80 | 0.270 |
Why?
|
| European Continental Ancestry Group | 5 | 2019 | 476 | 0.270 |
Why?
|
| United States | 6 | 2025 | 3866 | 0.270 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 119 | 0.260 |
Why?
|
| Annexin A2 | 3 | 2001 | 3 | 0.250 |
Why?
|
| Treatment Outcome | 7 | 2022 | 1160 | 0.240 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 1151 | 0.230 |
Why?
|
| Budesonide | 2 | 2001 | 2 | 0.230 |
Why?
|
| Minority Groups | 2 | 2023 | 104 | 0.230 |
Why?
|
| Hypertension | 2 | 2023 | 469 | 0.230 |
Why?
|
| Needs Assessment | 1 | 2025 | 65 | 0.230 |
Why?
|
| Adolescent | 8 | 2022 | 3538 | 0.230 |
Why?
|
| Spatial Analysis | 1 | 2024 | 11 | 0.220 |
Why?
|
| Pre-Eclampsia | 1 | 2025 | 40 | 0.220 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2025 | 61 | 0.220 |
Why?
|
| Community Networks | 1 | 2024 | 21 | 0.220 |
Why?
|
| Vegetables | 2 | 2019 | 88 | 0.220 |
Why?
|
| Fibrinolysin | 3 | 2001 | 3 | 0.220 |
Why?
|
| Health Promotion | 2 | 2023 | 279 | 0.220 |
Why?
|
| Emotions | 1 | 2024 | 34 | 0.220 |
Why?
|
| Gender Identity | 1 | 2024 | 33 | 0.220 |
Why?
|
| Body Weight | 4 | 2018 | 203 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 312 | 0.210 |
Why?
|
| Precision Medicine | 1 | 2023 | 29 | 0.200 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2023 | 24 | 0.200 |
Why?
|
| Program Evaluation | 2 | 2016 | 205 | 0.200 |
Why?
|
| Health Status | 2 | 2023 | 293 | 0.200 |
Why?
|
| Cocaine | 1 | 2023 | 7 | 0.200 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 68 | 0.190 |
Why?
|
| Bronchodilator Agents | 1 | 2001 | 22 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2022 | 211 | 0.180 |
Why?
|
| Fibroma | 1 | 2021 | 2 | 0.180 |
Why?
|
| Gingival Neoplasms | 1 | 2021 | 2 | 0.180 |
Why?
|
| Residence Characteristics | 1 | 2023 | 253 | 0.180 |
Why?
|
| Cannabis | 1 | 2023 | 85 | 0.170 |
Why?
|
| Bariatric Surgery | 1 | 2022 | 129 | 0.170 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 173 | 0.160 |
Why?
|
| Quality of Life | 2 | 2014 | 499 | 0.160 |
Why?
|
| Pregnancy | 1 | 2025 | 1463 | 0.160 |
Why?
|
| Evidence-Based Medicine | 2 | 2023 | 169 | 0.160 |
Why?
|
| Phentermine | 1 | 2019 | 10 | 0.160 |
Why?
|
| Appetite Depressants | 1 | 2019 | 16 | 0.160 |
Why?
|
| Risk Factors | 3 | 2016 | 3258 | 0.160 |
Why?
|
| Mental Health Services | 1 | 2021 | 155 | 0.150 |
Why?
|
| Stair Climbing | 1 | 2019 | 1 | 0.150 |
Why?
|
| Healthy Aging | 1 | 2019 | 8 | 0.150 |
Why?
|
| Social Support | 2 | 2018 | 207 | 0.150 |
Why?
|
| Urban Population | 2 | 2016 | 109 | 0.150 |
Why?
|
| Diet Therapy | 1 | 2018 | 9 | 0.150 |
Why?
|
| Choice Behavior | 2 | 2016 | 45 | 0.150 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 425 | 0.140 |
Why?
|
| Self Report | 2 | 2023 | 257 | 0.140 |
Why?
|
| Exercise Therapy | 1 | 2018 | 72 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2019 | 149 | 0.140 |
Why?
|
| Women's Health | 1 | 2019 | 197 | 0.140 |
Why?
|
| Mentoring | 1 | 2017 | 26 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 2017 | 306 | 0.130 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 605 | 0.130 |
Why?
|
| Insurance Coverage | 1 | 2017 | 104 | 0.130 |
Why?
|
| Ethnic Groups | 1 | 2019 | 451 | 0.130 |
Why?
|
| Health Personnel | 1 | 2017 | 126 | 0.120 |
Why?
|
| Qualitative Research | 1 | 2017 | 260 | 0.120 |
Why?
|
| Child | 5 | 2014 | 2403 | 0.120 |
Why?
|
| Cohort Studies | 5 | 2022 | 2514 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 437 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 310 | 0.120 |
Why?
|
| Goals | 1 | 2015 | 27 | 0.120 |
Why?
|
| Respiratory Rate | 1 | 2015 | 1 | 0.120 |
Why?
|
| Emigration and Immigration | 1 | 2015 | 14 | 0.120 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 3 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2014 | 7 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2015 | 105 | 0.110 |
Why?
|
| Patient Compliance | 2 | 2014 | 277 | 0.110 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 43 | 0.110 |
Why?
|
| Video Recording | 1 | 2014 | 12 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 357 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 30 | 0.110 |
Why?
|
| Bulimia | 1 | 2014 | 8 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2013 | 48 | 0.110 |
Why?
|
| Counseling | 1 | 2015 | 174 | 0.110 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 46 | 0.100 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2011 | 10 | 0.100 |
Why?
|
| Pediatric Obesity | 1 | 2014 | 88 | 0.100 |
Why?
|
| African Continental Ancestry Group | 1 | 2013 | 144 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 355 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 151 | 0.100 |
Why?
|
| Binge-Eating Disorder | 1 | 2013 | 13 | 0.100 |
Why?
|
| Nutrition Surveys | 1 | 2012 | 56 | 0.100 |
Why?
|
| Patient Participation | 1 | 2013 | 119 | 0.100 |
Why?
|
| Culture | 2 | 2009 | 30 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 535 | 0.100 |
Why?
|
| Motor Activity | 1 | 2014 | 208 | 0.090 |
Why?
|
| Neutrophils | 1 | 2011 | 2 | 0.090 |
Why?
|
| New York City | 1 | 2011 | 24 | 0.090 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2011 | 13 | 0.090 |
Why?
|
| Family Characteristics | 2 | 2014 | 57 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 701 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2011 | 23 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 367 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 69 | 0.090 |
Why?
|
| Patient Selection | 1 | 2013 | 176 | 0.090 |
Why?
|
| Forced Expiratory Volume | 1 | 2011 | 70 | 0.090 |
Why?
|
| Cities | 1 | 2011 | 30 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 532 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2011 | 82 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 66 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 298 | 0.090 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2011 | 89 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 120 | 0.080 |
Why?
|
| Disease Progression | 1 | 2011 | 259 | 0.080 |
Why?
|
| Nutritive Value | 1 | 2009 | 11 | 0.080 |
Why?
|
| Plasminogen | 2 | 2000 | 2 | 0.080 |
Why?
|
| Perception | 1 | 2009 | 56 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2000 | 24 | 0.080 |
Why?
|
| Veterans | 1 | 2010 | 145 | 0.080 |
Why?
|
| Hispanic Americans | 1 | 2011 | 375 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 1925 | 0.070 |
Why?
|
| Chicago | 2 | 2019 | 25 | 0.070 |
Why?
|
| Urban Health | 1 | 2006 | 36 | 0.070 |
Why?
|
| Food Preferences | 1 | 2006 | 23 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 65 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2022 | 2415 | 0.060 |
Why?
|
| Administration, Inhalation | 2 | 2001 | 40 | 0.060 |
Why?
|
| Animals | 3 | 2001 | 280 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2001 | 142 | 0.060 |
Why?
|
| Consensus | 1 | 2023 | 40 | 0.050 |
Why?
|
| Social Justice | 1 | 2023 | 7 | 0.050 |
Why?
|
| Cattle | 2 | 2001 | 9 | 0.050 |
Why?
|
| Prevalence | 2 | 2019 | 840 | 0.050 |
Why?
|
| Boston | 1 | 2023 | 28 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2000 | 8 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2023 | 14 | 0.050 |
Why?
|
| Substance Abuse Detection | 1 | 2023 | 18 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2000 | 6 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2022 | 47 | 0.050 |
Why?
|
| Recurrence | 1 | 2022 | 165 | 0.050 |
Why?
|
| Internet | 2 | 2014 | 212 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2001 | 4 | 0.050 |
Why?
|
| Time | 1 | 2001 | 20 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 384 | 0.050 |
Why?
|
| Withholding Treatment | 1 | 2001 | 26 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 226 | 0.050 |
Why?
|
| Depression | 2 | 2018 | 486 | 0.050 |
Why?
|
| Child Welfare | 1 | 2001 | 40 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2023 | 275 | 0.050 |
Why?
|
| Fibrin | 1 | 2001 | 1 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2001 | 2 | 0.040 |
Why?
|
| Infant | 2 | 2001 | 1161 | 0.040 |
Why?
|
| Masks | 1 | 2000 | 5 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2000 | 27 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2000 | 1 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 5 | 0.040 |
Why?
|
| Cell Line | 1 | 2000 | 11 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 245 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2000 | 38 | 0.040 |
Why?
|
| Kidney | 1 | 2000 | 52 | 0.040 |
Why?
|
| Hospitalization | 1 | 2025 | 804 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1998 | 6 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2019 | 15 | 0.040 |
Why?
|
| Michigan | 1 | 2019 | 28 | 0.040 |
Why?
|
| Time Factors | 1 | 2001 | 1039 | 0.040 |
Why?
|
| Alabama | 2 | 2009 | 23 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 1380 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2018 | 185 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 674 | 0.030 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1996 | 1 | 0.030 |
Why?
|
| Oxidants | 1 | 1996 | 2 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 1996 | 4 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1996 | 5 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1996 | 2 | 0.030 |
Why?
|
| Television | 1 | 2014 | 16 | 0.030 |
Why?
|
| Adolescent Health Services | 1 | 2014 | 40 | 0.030 |
Why?
|
| Sleep | 1 | 2014 | 57 | 0.030 |
Why?
|
| Health Education | 1 | 2014 | 82 | 0.030 |
Why?
|
| Child Health Services | 1 | 2014 | 105 | 0.030 |
Why?
|
| Personality Inventory | 1 | 2013 | 12 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2013 | 26 | 0.020 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 34 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 186 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 342 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 560 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2010 | 32 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 63 | 0.020 |
Why?
|
| Cooking | 1 | 2009 | 17 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2009 | 28 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 603 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 878 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 1998 | 14 | 0.020 |
Why?
|
| School Health Services | 1 | 2006 | 39 | 0.020 |
Why?
|
| Focus Groups | 1 | 2007 | 143 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2001 | 2 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 12 | 0.010 |
Why?
|
| Glycerol | 1 | 2001 | 5 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 45 | 0.010 |
Why?
|
| Lung | 1 | 2001 | 60 | 0.010 |
Why?
|
| Suspensions | 1 | 2000 | 1 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2000 | 5 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2000 | 23 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 99 | 0.010 |
Why?
|
| alpha-2-Antiplasmin | 1 | 1998 | 1 | 0.010 |
Why?
|
| Aminocaproic Acid | 1 | 1998 | 1 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 1 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1998 | 3 | 0.010 |
Why?
|
| Lysine | 1 | 1998 | 2 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1998 | 5 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 16 | 0.010 |
Why?
|
| Epithelium | 1 | 1996 | 2 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 1996 | 2 | 0.010 |
Why?
|
| Cell Division | 1 | 1996 | 5 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 1996 | 20 | 0.010 |
Why?
|
| Mice | 1 | 1996 | 80 | 0.010 |
Why?
|
Concepts
(273)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->